#6: FastFun: Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Company Plans to File Supplemental New Drug Application with FDA in... |
October 17, 2007
02:44:50 AM |
#5: FastFun: Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
- Significant Efforts to Expand Market and Prepare for Zingo Launch... |
October 17, 2007
02:44:12 AM |
#4: FastFun: Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
Sagent to Accelerate Anesiva's Penetration of the Hospital Market with... |
October 17, 2007
02:43:33 AM |
#3: FastFun: Anesiva Defines Regulatory Pathway for Adlea with FDA
New Phase 3 Plan Could Expedite Clinical Development Pathway
SOUTH SAN... |
October 17, 2007
02:42:59 AM |
#2: FastFun: Anesiva to Present at BIO InvestorForum on October 11, 2007
SOUTH SAN FRANCISCO, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Anesiva,... |
October 17, 2007
02:42:30 AM |
#1: FastFun: Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
Adlea May Provide Pain Relief Without Opiate-Like Side Effects For Weeks... |
October 17, 2007
02:42:01 AM |
|
Tips for using stock message boards discussion forums
|
| 
| 
| 
| 
| 
| 
